NIDDK News

News and events from NIDDK-funded research and programs.

Media Inquiries

Dr. William T. Cefalu to direct NIDDK Division of Diabetes, Endocrinology, and Metabolic Diseases

Statement from NIDDK Director Dr. Griffin P. Rodgers

I am delighted to announce Dr. William T. Cefalu as the new director of the Division of Diabetes, Endocrinology, and Metabolic Diseases at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. An expert physician researcher, leader, and patient advocate, Dr. Cefalu will be responsible for setting scientific priorities within a large and diverse program of basic and clinical research. Over the past 35 years, Dr. Cefalu has established a stellar career in service to public health, including in his most recent role as chief scientific, medical, and mission officer of the American Diabetes Association (ADA). Prior to his role at the ADA, he served in leadership positions at Louisiana State University’s Pennington Biomedical Research Center in Baton Rouge, La. He has authored over 300 publications and five books on diabetes. I know Dr. Cefalu will make outstanding contributions in his new role.

Latest News

NIH grantees win 2019 Nobel Prize in Physiology or Medicine

Oct. 7, 2019

NIH funding bolsters rare diseases research collaborations

Oct. 3, 2019

NIH funds $945 million in research to tackle the national opioid crisis through NIH HEAL Initiative

Sept. 26, 2019

Prolonged antibiotic treatment may alter preterm infants’ microbiome

Sept. 9, 2019

Scientists triple storage time of human donor livers

Sept. 9, 2019

Intensive blood pressure control may slow age-related brain damage

Aug. 13, 2019

“Wildling” mice could help translate results in animal models to results in humans

Aug. 1, 2019

NIH publishes the largest genomic study on type 2 diabetes in sub-Saharan African populations

July 19, 2019

Moderate calorie restriction in young and middle-aged adults significantly reduces heart and metabolic risk factors independent of weight loss

July 12, 2019

Drug delays type 1 diabetes in people at high risk

June 10, 2019

Improvements in insulin release wane after treatment stops in adults with early type 2 diabetes

June 10, 2019

View all News

More News

For Reporters

NIDDK's Press Team can provide access to researchers and program staff and guide you to the latest information and research on diabetes, obesity, and digestive and kidney diseases from NIDDK.

Follow NIDDK on social media
- Twitter, Facebook, and YouTube - for the latest information about the Institute’s initiatives, events, studies and funding opportunities.